Analysis of Donor Biopsy Tissue Samples at the Time of Kidney Transplant
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01271465|
Recruitment Status : Recruiting
First Posted : January 6, 2011
Last Update Posted : March 27, 2018
|Condition or disease||Intervention/treatment|
|Kidney Transplantation||Procedure: Kidney Biopsy|
Early post-transplant kidney function can be attributed to inherent donor characteristics, damage from storage, and perioperative events and recipients factors. The incidence of severe injury to the transplant kidneys is 10-25% in the early post-transplant period. In addition, milder forms of early transplant kidney injury can impact on long term allograft function. Severe transplant kidney injury in the immediate post-transplant period has been hypothesized to be associated with higher rates of rejection.
In the current investigation, we would like to test the hypotheses that 1) mRNA and microRNA expression of proinflammatory genes in donor tissues is a risk factor for development of early kidney transplant dysfunction and 2) early inflammatory mRNA and microRNA expression in the allograft is associated with subsequent activation of cell mediated immunity as evidenced by increased incidence of acute rejection episodes and increased expression of cell mediated immunity genes during the first year post-transplant.
Aim 1: Test the association between proinflammatory mRNA and microRNA expression in donor samples and subsequent development of early organ dysfunction in the immediate period following transplantation.
Aim 2: Test the association of mRNA and microRNA expression of proinflammatory mediators in the transplanted organ in the immediate pre and post-reperfusion period with subsequent incidence of acute rejection and expression of genes involved in cell mediated immunity.
|Study Type :||Observational|
|Estimated Enrollment :||120 participants|
|Official Title:||mRNA and microRNA Profiles in Renal Transplant at the Time of Organ Reperfusion|
|Actual Study Start Date :||September 2010|
|Estimated Primary Completion Date :||December 2020|
|Estimated Study Completion Date :||December 2025|
Procedure: Kidney Biopsy
- Incidence of early organ dysfunction, defined by standard criteria for each organ defined as the need for dialysis within 7 days after transplant and incidence of biopsy proven acute cellular rejection within 12 months of transplant [ Time Frame: 7 days and 12 months, respectively ]
- Serum Creatinine [ Time Frame: 24 months ]Correlation between proinflammatory mediators at the time of transplantation and renal function as measured by serum creatinine
- Incidence of chronic allograft nephropathy [ Time Frame: 24 months ]Correlation between proinflammatory mediators at the time of transplantation and incidence of chronic allograft nephropathy
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01271465
|Contact: Sandip Kapur, MD||(212) email@example.com|
|United States, New York|
|Weill Cornell Medical College||Recruiting|
|New York, New York, United States, 10065|
|Contact: Sandip Kapur, MD 212-746-5330 firstname.lastname@example.org|
|Principal Investigator: Sandip Kapur, MD|
|Principal Investigator:||Sandip Kapur, MD||Weill Cornell Medicine/Department of Surgery|